Serendex Pharmaceuticals A/S is a biopharmaceutical development company based in Hørsholm, Denmark, which focuses on the development of medicinal products for the treatment of respiratory diseases. With the acquisition of Serendex, Savara Pharmaceuticals Inc. will be able to add two new programmes to its pipeline. The acquisition, which is expected to be completed in mid-July, is subject to the usual terms and conditions. Click the link to the right to read more about the acquisition of Serendex Pharmaceuticals A/S.
